key: cord-0851482-0r9o2uec authors: Kesmez Can, Fatma; Özkurt, Zülal; Öztürk, Nurinnisa; Sezen, Selma title: Effect of IL‐6, IL‐8/CXCL8, IP‐10/CXCL 10 levels on the severity in COVID 19 infection date: 2021-10-22 journal: Int J Clin Pract DOI: 10.1111/ijcp.14970 sha: 025d58730f7e8da3ce117d3dbab9b21c2e123e77 doc_id: 851482 cord_uid: 0r9o2uec BACKGROUND: COVID 19 was first observed in December 2019 and has affected the world entire. Effective laboratory markers and prognostic indicators are needed to predict the clinical progression of the disease. AIMS: The purpose of this study was to investigate IL6, IL8/CXCL8, and IP10/CXCL10, and biochemical parameters associated with SARS, MERS, and SARS‐CoV‐2 infections and their significance on prognosis in healthy volunteers and mild‐moderate and severe COVID 19 patients. METHODS: Healthy volunteers (n = 30), and patients with mild‐moderate (n = 30) and severe (n = 30) COVID‐19 patients were included in the study. IL‐6, IL‐8, and IP‐10 levels and biochemical parameters were assessed among the groups and their correlations with each other were subjected to statistical analysis. RESULTS: Blood serum IL‐6, IL‐8, and IP‐10 levels were the highest in the severe patient group (P = .001), and also higher in the mild‐moderate group as compared with the healthy volunteers (P = .001). Statistically significant positive correlations were identified between serum IL‐8 and IL‐6 levels (P = .001, r = 0.660), between serum IP‐10 and IL‐6 (P = .001, r = 0.599) and between serum IP‐10 and IL‐8 (P = .001, r = 0.729). CONCLUSIONS: A statistically significant difference was found in WBC, NE%, NE, LY%, LY, HB, BUN, total protein, albumin, d‐dimer, sedimentation differed significantly between the groups. Biomarkers of potential significance in terms of the severity of COVID 19 disease were examined, and high IL‐6, IL‐8, IP‐10, CRP, PCT, and LY parameters values emerged as associated with the severity of the disease. acute lung injury followed by acute respiratory distress syndrome (ARDS). 4, 5 The stimulation of the host's innate and adaptive immunity including activation of T cells, CD4 and CD8+T cells production of several proinflammatory cytokines are required to control viral replication after viral infections, to limit the spread of the virus and to kill infected cells. However, tissue damage because of the virus may induce the exaggerated production of proinflammatory cytokines, macrophages, granulocytes and other immune cells. 6 Several clinical studies have proposed blocking cytokine production or lowering their blood levels as possible solutions. [7] [8] [9] However, the pandemic period continues, and for possible treatments, more randomised controlled studies are required to understand the pathogenesis of the infection. Researchers in different centres worldwide have compared patients clinical characteristics by means of molecular, biochemical and radiological assays to determine the course of the disease progression. 10, 11 However, these investigations were performed on a limited number of patients, and the published data are different from each other. Since IL-6, IL-8 (CXCL 8), and IP-10 (CXCL 10) from the cytokine and chemokine family are known to be significant in SARS and MERS, their significance in SARS-CoV-2 (COVID- 19) infection is still the subject of investigation. 12, 13 This study, we investigated the role of the relationship between IL-6, IL-8, and IP-10 levels, routine biochemical parameters (white blood cell (WBC), neutrophil (NE), LY, haemoglobin (HB), platelets (PLT), BUN, total protein, albumin, d-dimer, sedimentation, creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), creatine kinase (CK), troponin, C-reactive protein, ferritin, and procalcitonin (PCT)) and IL-6, IL-8, IP-10 levels in the prognosis of COVID-19 in healthy individuals, mildmoderate and in severe COVID-19 patients. The control groups (n = 30) consisted of healthy volunteers who had not been diagnosed with COVID- 19 All patients in the study were informed about the study, and their written and verbal consents were obtained. Blood samples were taken from mild-moderate and severe patients with positive COVID-19 RT-PCR test on the first day. The sitting position after blood from the antecubital area was taken into biochemistry tubes by experienced people using a vacutainer. The samples were centrifuged after coagulation at room temperature for 30 minutes, and serum samples were separated. They were frozen and stored at −80°C until analysis. After the serum samples were dissolved under optimal conditions for analysis, all analyzes were performed in a single session at the Medical Biochemistry Laboratory of the Atatürk University Health Research and Practice Center. disease. • The severity of the disease should be determined before the cytokine storm begins. • In this article, IL-6, IL-8/CXCL8, IP-10/CXCL 10 are recommended as early prognostic inflammatory parameters to determine the severity of COVID 19 Disease. Troponin, CRP, Ferritin, PCT parameters. The results of routine assays were taken from the hospital database. In addition, neutrophil-lymphocyte ratio (NLR) and Prognostic Nutritional Index (PNI) were calculated for all groups. While calculating NLR, the NE/LY method was used. For PNI calculation; the formula of ×10 serum albumin +0.005× peripheral lymphocyte count was used. were given as mean ± standard deviation (mean ± SD) and minimummaximum (min-max). P < .05 was used for significant differences between the groups. Statistical analysis was performed by SPSS 20.0 (SPSS) program. Table 1 . Also, there was no statistically significant difference in IL-6, IL-8, IP-10 levels among 9 ex and 21 discharged patients in the severe patient group. We found a statistically significant positive correlation between serum IL-8 and IL-6 levels (P = .001, r = 0.660; Table 2 and Figure 1 ). A statistically significant positive correlation was found between serum IP-10 and IL-6 (P = .001, r = 0.599; Table 2 and Figure 2) . A statistically significant positive correlation was found between serum IP-10 and IL-8 (P = .001, r = 0.729; Table 2 and Figure 2 ). Routine blood parameters were evaluated by IP-10. A statistically significant positive correlation was found between IP-10 (pg/ mL)/CRP (P = .000, r = 0.711), IP-10 (pg/mL)/Ferritin (P = .000, r = 0.550), IP-10 (pg/mL)/PCT. A statistically negative significant correlation was found between IP-10 (pg/mL)/LY (P = .004, r = −0.362). No significant relationship was found between IP-10 (pg/mL)/ddimer (P = .208, r = 0.165; Table 3 ). Routine blood parameters were evaluated by IL-8. A statistically positive significant correlation was found between IL-8 (pg/mL)/CRP (P = .000, r = 0.468), IL-8 (pg/mL)/Ferritine (P = .002, r = 0.387), IL-8 (pg/mL)/PCT (P = .000, r = 0.518), IL-8 (pg/mL)/d-dimer (P = .017, r = 0.307). A negative significant correlation was found between IL-8 (pg/mL)/LY (P = .012, r = −0.322; Table 3 ). Routine blood parameters were evaluated by IL-6. A statistically positive significant correlation was found between IL-6 (pg/mL)/ CRP (P = .040, r = 0.265), IL-6 (pg/mL)/PCT (P = .019, r = 0.303). A significant negative correlation was found between IL-6 (pg/mL)/LY (P = .006, r = −0.352). No significant relationship was found between IL-6 (pg/mL)/Ferritin (P = .285, r = 0.140) and IL-6 (pg/mL)/d-dimer (P = .203 r = 0.167; Table 3 ). Routine blood parameters followed up in the mild-moderate and severe COVID 19 patient groups were compared. A statistically significant difference was found in WBC, NE%, NE, LY%, LY, HB, BUN, Total protein, Albumin, d-dimer, Sedimentation values between the groups. PLT (P = .094) the value was not statistically significant. LY%, LY, HB, albumin, and total protein values were significantly lower in severe patient groups. NLR rate was higher in the severe patient group. PNI was lower in the severe patient group ( TA B L E 1 IL-6, IL-8, and IP 10 blood serum levels of the groups severe patient group and statistically significant (P < 0,005). No significant relationship was found between groups in creatin, AST, ALT parameters (P > 0,005; Table 5 ). Cytokines are studied as an important marker in the prognosis of COVID 19 infection, and the effects of cytokines vary depending on the targeted cell. Different cytokines may have similar effects or exhibit synergistic effects. 14 Its role is the regulation of immune response, autoimmune mechanisms and acute phase responses. 15 In the studies on SARS-CoV-2 infection, almost all researchers reported that IL-6 is associated with cytokine storm, ARDS and poor prognosis with mortality. [16] [17] [18] Studies patients with lower respiratory infections, and that the, increase in IL-8 and IP-10 is associated with the disease severity. They also reported a persistent increase in IP-10, a chemokine-induced rapidly and temporarily during viral infections, in COVID-19 and that this is associated with severity. 6 F I G U R E 1 Correlation between IL-8 and IL-6 blood serum levels in all groups to be associated with poor prognosis (Figures 1-3) . When the effect on survival was examined, there was no statistically significant difference in IL-6, IL-8, IP-10 levels among 9 ex and 21 discharged patients in the severe patient group. It was thought that this situation might be related to the small number of groups compared and the advanced age of the patients who died. In the studies, which were performed to determine the progno- 24 It was reported that the number of leukocytes decreases in the early stage of the disease, however increases in the later stage. The inflammatory response may stimulate neutrophile production and may accelerate apoptosis of lymphocytes. Considering the increased neutrophils and decreased lymphocyte count, NLR was calculated as an inflammation marker. Our study showed that NLR was high in the severe patient group. The other studies showed that the higher levels of inflammatory cytokines, chemokine, and NLR in the SARS-CoV-2 patients may be associated with the disease severity as compared with the non-severe patients. 25 CRP and PCT in our study. 18 The Asian and European studies reported that LDH and Ferritin levels were high in the patients with severe disease resulting in death while being treated in the intensive care units. 17, 27 Abnormal levels of LDH and Ferritin may be associated with infections, cytokine-induced tissue damage, multi-organ damage, decreased oxygenation. Cytokine storm in the severe patient groups is considered as an important biomarker in the progression to ARDS and multi-organ damage. 28 In line with the literature, we found that LDH and ferritin are high in the severe patient group. 29 Given that IL-6 and IP-10 are not correlated with d-dimer, we suggested that they might be associated with these conditions. This study evaluated some inflammatory and biochemical mark- Projects Coordination Unit (Project code: THD-2020-8619). Thank you to Atatürk University for their support. Fatma Kesmez Can, Zülal Özkurt, Nurinnisa Öztürk and Selma Sezen declare that they have no conflict of interest. The epidemiology and clinical information about COVID-19 World Health Organization. WHO coronavirus disease (COVID-19) dashboard Serum cytokine and chemokine profile in relation to the severity of coronavirus disease 2019 in China The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 A dynamic COVID-19 immune signature includes associations with poor prognosis CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: a structured summary of a study protocol for a randomized controlled trial Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): a structured summary of a study protocol for a randomised controlled trial IL-6 inhibitors in the treatment of serious COVID-19: a promising therapy Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan Interferon and cytokine responses to SARScoronavirus infection Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in Covid-19: key therapeutic targets? Front Immunol Cytokines in inflammatory disease The bio-mission of interleukin-6 in the pathogenesis of COVID-19: a brief look at potential therapeutic tactics An inflammatory cytokine signature predicts COVID-19 severity and survival Clinical features of patients infected with 2019 novel coronavirus in Wuhan The potential role of IL-6 in monitoring coronavirus disease 2019 Cytokine release syndrome (CRS) and nicotine in COVID-19 patients: trying to calm the storm IP-10 in occupational asthma: review of the literature and case-control study IP-10 is highly involved in HIV infection Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China Diagnostic utility of Creactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19 Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection